We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Scientist Suggests Clinical Trials With Low-dose Rapamycin To Protect Elderly From COVID-19

News   Apr 07, 2020 | Original story from Aging

 
Scientist Suggests Clinical Trials With Low-dose Rapamycin To Protect Elderly From COVID-19

Credit: Pixabay

 
 
Advertisement
 

RELATED ARTICLES


Findings From Small Study Suggest COVID-19 Could Cause Changes in the Placenta

News

The placentas from 16 women who tested positive for COVID-19 while pregnant showed evidence of injury, according to pathological exams completed directly following birth, reports a new Northwestern Medicine study.

READ MORE

Why Is Sex So Popular? Microbe Study Suggests Stress Reduction Role

News

Why is sex so popular? The question of why so many organisms reproduce sexually has mystified evolutionary biologists since before Darwin. A new study, suggests that the molecular mechanisms underlying sex and the stress response may be more tightly coupled than previously appreciated, providing a new explanation for the widespread prevalence of sex in nature.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE